NCT-505
Product Specifications
UNSPSC Description
NCT-505 is a potent and selective aldehyde dehydrogenase (ALDH1A1) inhibitor, with an IC50 of 7 nM, and weakly inhibits hALDH1A2, hALDH1A3, hALDH2, hALDH3A1 (IC50s, >57, 22.8, 20.1, >57 μM).
Target Antigen
Aldehyde Dehydrogenase (ALDH)
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/NCT-505.html
Purity
99.37
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
N#CC1(C2=CC=CC=C2)CCN(C3=C(C(N4CCN(S(=O)(C)=O)CC4)=O)C=NC5=CC=C(F)C=C35)CC1
Molecular Weight
521.61
References & Citations
[1]Yang SM, et al. Discovery of Orally Bioavailable, Quinoline-Based Aldehyde Dehydrogenase 1A1 (ALDH1A1) Inhibitors with Potent Cellular Activity. J Med Chem. 2018 Jun 14;61(11):4883-4903.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-112277/NCT-505-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-112277/NCT-505-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
2231079-74-4
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1074568-01 1 mg (E-Coli)
Recombinant Yersinia pseudotuberculosis serotype O:3 Protoheme IX farnesyltransferase (cyoE), partial
Ask
View Details 
MBS1074568-02 1 mg (Yeast)
Recombinant Yersinia pseudotuberculosis serotype O:3 Protoheme IX farnesyltransferase (cyoE), partial
Ask
View Details 